Ad is loading...
AKRO
Price
$31.20
Change
+$0.56 (+1.83%)
Updated
Nov 21 closing price
111 days until earnings call
PLRX
Price
$12.85
Change
+$0.12 (+0.94%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

AKRO vs PLRX

Header iconAKRO vs PLRX Comparison
Open Charts AKRO vs PLRXBanner chart's image
Akero Therapeutics
Price$31.20
Change+$0.56 (+1.83%)
Volume$534.96K
CapitalizationN/A
Pliant Therapeutics
Price$12.85
Change+$0.12 (+0.94%)
Volume$691.73K
CapitalizationN/A
AKRO vs PLRX Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AKRO vs. PLRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Hold and PLRX is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (AKRO: $31.20 vs. PLRX: $12.85)
Brand notoriety: AKRO and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 92% vs. PLRX: 151%
Market capitalization -- AKRO: $2.14B vs. PLRX: $781.97M
AKRO [@Biotechnology] is valued at $2.14B. PLRX’s [@Biotechnology] market capitalization is $781.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, AKRO is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than PLRX.

Price Growth

AKRO (@Biotechnology) experienced а +4.84% price change this week, while PLRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.14B) has a higher market cap than PLRX($782M). AKRO YTD gains are higher at: 33.619 vs. PLRX (-29.045). PLRX has higher annual earnings (EBITDA): -197.04M vs. AKRO (-232.85M). AKRO has more cash in the bank: 717M vs. PLRX (405M). AKRO has less debt than PLRX: AKRO (36.4M) vs PLRX (60.2M). AKRO (0) and PLRX (0) have equivalent revenues.
AKROPLRXAKRO / PLRX
Capitalization2.14B782M273%
EBITDA-232.85M-197.04M118%
Gain YTD33.619-29.045-116%
P/E RatioN/AN/A-
Revenue00-
Total Cash717M405M177%
Total Debt36.4M60.2M60%
TECHNICAL ANALYSIS
Technical Analysis
AKROPLRX
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIGIX17.770.26
+1.48%
Morgan Stanley Inst Global Insgt I
FNEEX66.790.30
+0.45%
American Funds New Economy 529-F-2
LICPX15.22N/A
N/A
Lord Abbett International Equity P
GGOTX17.27N/A
N/A
Goldman Sachs Mid Cap Growth Inv
BGESX13.72N/A
N/A
Baillie Gifford International Growth I

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+0.94%
NTLA - PLRX
51%
Loosely correlated
+5.18%
RCKT - PLRX
51%
Loosely correlated
-1.92%
BEAM - PLRX
50%
Loosely correlated
-3.72%
ABSI - PLRX
49%
Loosely correlated
-4.85%
PRME - PLRX
48%
Loosely correlated
-0.67%
More